Associations between biomarker testing and characteristics of patients with metastatic non–small cell lung cancer (mNSCLC): An analysis of CancerLinQ Discovery (CLQD) data.

Authors

null

Kathryn Finch Mileham

Levine Cancer Institute, Atrium Health, Charlotte, NC

Kathryn Finch Mileham , Elizabeth Garrett-Mayer , Melinda Kaltenbaugh , Margaret Kelsey Kirkwood , Caroline Schenkel , Suanna Steeby Bruinooge , Raymond U. Osarogiagbon , Shadia Ibrahim Jalal , Amy Moore , Upal Kunal Basu Roy , Janet Freeman-Daily , Shamsuddin Virani , Edward B. Garon , Gerard A. Silvestri , Lauren Rosenthal , Robert A. Smith , Bruce E. Johnson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9127)

DOI

10.1200/JCO.2022.40.16_suppl.9127

Abstract #

9127

Poster Bd #

113

Abstract Disclosures

Similar Posters